deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT03606486

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Lavage of the Uterine Cavity for Diagnosis of Ovarian Carcinomas

Sponsor: Minnesota Ovarian Cancer Alliance

Conditions High Grade Ovarian Serous Adenocarcinoma Stage III Ovarian Cancer AJCC v8 Stage IIIA Ovarian Cancer AJCC v8 Stage IIIA1 Ovarian Cancer AJCC v8 Stage IIIA2 Ovarian Cancer AJCC v8 Stage IIIB Ovarian Cancer AJCC v8 Stage IIIC Ovarian Cancer AJCC v8 Stage IV Ovarian Cancer AJCC v8 Stage IVA Ovarian Cancer AJCC v8 Stage IVB Ovarian Cancer AJCC v8
Interventions Biospecimen Collection Laboratory Biomarker Analysis Lavage Pap Smear
Updated 16 times since 2018 Last updated: Dec 26, 2023 Started: Nov 16, 2018 Primary completion: Dec 9, 2022 Completion: Dec 9, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated due to low accrual

This NA trial investigates High Grade Ovarian Serous Adenocarcinoma and Stage III Ovarian Cancer AJCC v8 and is currently terminated or withdrawn. Minnesota Ovarian Cancer Alliance leads this study, which shows 16 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Oct 2019 · 7 months · monthly snapshot~Oct 2019 – ~Sep 2020 · 11 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Oct 2021 · 7 months · monthly snapshot~Oct 2021 – ~Apr 2022 · 6 months · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Feb 2024 · 12 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Feb 2024 — Jul 2024 [monthly]

    Terminated NA

  4. Feb 2023 — Feb 2024 [monthly]

    Terminated NA

  5. Jan 2023 — Feb 2023 [monthly]

    Terminated NA

    Status: Recruiting → Terminated

▶ Show 11 earlier versions

  1. Sep 2022 — Jan 2023 [monthly]

    Recruiting NA

  2. Apr 2022 — Sep 2022 [monthly]

    Recruiting NA

  3. Oct 2021 — Apr 2022 [monthly]

    Recruiting NA

  4. Mar 2021 — Oct 2021 [monthly]

    Recruiting NA

  5. Jan 2021 — Mar 2021 [monthly]

    Recruiting NA

  6. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

  7. Oct 2019 — Sep 2020 [monthly]

    Recruiting NA

  8. Mar 2019 — Oct 2019 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  9. Jan 2019 — Mar 2019 [monthly]

    Not Yet Recruiting NA

  10. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting NA

  11. Aug 2018 — Dec 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Minnesota Ovarian Cancer Alliance
  • University of Washington
Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations